Locus Cell Co., Ltd. (TPEX: 6891)
Health Care · Life Sciences Tools & Services · TW
NT$48.95
+14.50% today · +48.6% 1Y
Locus Cell Co., Ltd. (TPEX: 6891) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $307.05M and employs 53 people.
Over the last twelve months the share price has gained 48.6%, trading between 23.90 and 94.70.
Tweenvest scores Locus Cell Co., Ltd. across four factors: quality 45/100, value 64/100. Its strongest factor is value.
6891 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $307.05M
- Revenue (TTM)
- $609.62K
- P/E
- —
- EPS
- -0.76
- Dividend yield
- —
- Beta (5Y)
- 2.41
- 52-week high
- NT$94.70
- 52-week low
- NT$23.90
- Avg volume (3M)
- —
- Shares outstanding
- 200.57M
- Employees
- 53
- Next earnings
- —
About Locus Cell Co., Ltd.
Locus Cell Co., Ltd. is a specialist in the biotechnology and cell therapy sector. The company primarily offers contract development and manufacturing (CDMO) services for a variety of cellular products. This includes handling diverse cell types such as adipose-derived stem cells, nerve cells, chondrocytes, and fibroblasts. Furthermore, their capabilities extend to advanced manufacturing processes like 3D bioprinting for cellular constructs. Locus Cell also provides CDMO support for cutting-edge regenerative medical products, including therapies based on CAR-T, mesenchymal stem cells (MSCs), and induced pluripotent stem cells (iPSCs).
- ISIN
- TW0006891005
- Listed since
- Apr 28, 2022
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Medtide Inc.SEHK: 3880 | $375.12M | HK$20.76 | -1.98% |
| Quantum-Si incorporatedNasdaqGM: QSI | $334.89M | $1.53 | +25.41% |
| Zhejiang Taimei Medical Technology Co., Ltd.SEHK: 2576 | $320.71M | HK$4.50 | -5.26% |
| Improve Medical Instruments Co., Ltd.SZSE: 300030 | $318.97M | CN¥6.91 | -0.14% |
| Frontage Holdings CorporationSEHK: 1521 | $286.41M | HK$1.11 | -6.36% |
| Nautilus Biotechnology, Inc.NasdaqCM: NAUT | $286.32M | $2.25 | +23.63% |
| Standard BioTools Inc.NasdaqGS: LAB | $270.64M | $0.69 | +2.85% |
| Penetrium Bioscience Inc.KOSDAQ: A187660 | $257.45M | ₩6,320.00 | -9.97% |
Figures last refreshed Oct 11, 2026.